ArticleBMC cardiovascular disorders2025
Spectrum of genetic variants detected in children tested for long QT syndrome.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLong QT syndrome (LQTS) is one of the most common inherited cardiac arrhythmias associated with sudden cardiac death worldwide. Despite the widespread implementation of next-generation sequencing, its diagnostic value remains limited due to challenges in interpreting the clinical significance of the identified variants. Since LQTS is rare and underreported in Baltic region, studies on small populations are valuable for expanding current knowledge on this rare cardiac channelopathy. Our aim was to evaluate the diagnostic yield of genetic testing and clinical manifestations of the disease in paediatric patients assessed for LQTS in Lithuania.
resultsThe phenotypic spectrum of LQTS among the cohort was notably heterogeneous, with more than half of the asymptomatic patients at the time of genetic testing. The overall diagnostic yield was 22%. The majority of pathogenic or likely pathogenic variants were detected in the KCNQ1 gene, with 17% of these categorised as high-risk for arrhythmic events. Individuals harbouring pathogenic or likely pathogenic variants showed significantly prolonged corrected QT (QTc) intervals in comparison to those without such variants.
conclusionsLess stringent referral criteria may reduce the diagnostic yield of genetic testing for LQTS. In our cohort, 17% of patients with 1 type LQTS had genetic variants located in regions associated with elevated arrhythmic risk. This knowledge should be considered as part of their individualised care plans. Furthermore, the identification of multiple variants of uncertain significance highlights the ongoing need for enhanced interpretive frameworks to integrate complex genetic findings into routine clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.